noradrenergic

Mirtazapine (6-Azamianserin) 是一种有效的具有口服活性的去甲肾上腺素能和特异性血清素能抗抑郁剂 (NaSSA)。它也是一种5-HT2、5-HT3、组胺 H1 受体和 α2-肾上腺素受体拮抗剂，pKi 值分别为 8.05、8.1、9.3 和 6.95。

Guanfacine hydrochloride (Intuniv) 是一种 α2A 肾上腺素受体激动剂，Kd=31 nM，具有抗高血压作用。

DSP-4 hydrochloride (Neurotoxin DSP 4 (hydrochloride)) 是一种高选择性的神经毒素，主要是来自蓝斑 (LC) 的神经元，容易通过血脑屏障。它对成年和发育中大鼠去甲肾上腺素能神经元具有神经毒性作用，可用于中枢和外周去甲肾上腺素能神经元的暂时选择性降解。

Brexpiprazole HCl (OPC 34712 dihydrochloride) 是一种新型抗精神病药物。

Viloxazine (Viloxazin) (Viloxazin) 是一种去甲肾上腺素再摄取抑制剂、5-HT 2C 受体激动剂和 5-HT 2B 受体拮抗剂。其主要作用机制是调节血清素能和去甲肾上腺素能途径。Viloxazine通常用于抑郁症研究 [1] [2]。

Carvacrol (O-Thymol) 是唇形科植物中的一种单萜酚类天然产物，具有镇痛、抗焦虑、抗抑郁、抗氧化、抗炎和抗癌作用。

Tizanidine 是一种 α2-肾上腺素受体激动剂，能够抑制神经递质从CNS 去甲肾上腺素激活的神经元中释放。

Tizanidine hydrochloride (Tizanidine HCl) 是一种 α2-肾上腺素受体激动剂，可抑制神经递质从 CNS 去甲肾上腺素激活的神经元中释放。

RGH-5526是一种新型的抗高血压药。它引起下丘脑去甲肾上腺素（NA）周转（利用）增加，下丘脑去甲肾上腺素能神经元活性的增加可能导致外周交感神经活性的降低，从而显著降低血压。

ONO-2952 is more selective for TSPO than other receptors, transporters, ion channels, and enzymes. ONO-2952 is a potent and selective translocator protein 18 kDa (TSPO) antagonist (Ki: 0.33-9.30 nM for rat and human TSPO). ONO-2952 has the potential for i

Pardoprunox (SLV-308) 是多巴胺受体D2、D3部分激动剂和5-HT1A 激动剂，pEC50分别为 8、9.2 和 6.3。

BE 2254 is an antagonist of central noradrenergic receptor.

R-84760 is a κ-opioid receptor agonist. R-84760 produces an extremely potent antinociceptive effect against tonic pain through the kappa-opioid receptors; the sites of action of subcutaneously administered R-84760 are the supraspinal and spinal loci in th

DSP 4 is a selective neurotoxin selective for noradrenergic neurons in the locus coeruleus noradrenergic system and capable of crossing the blood–brain barrier and cyclizes to a reactive aziridinium derivative that is accumulated into the noradrenergic ne

PSAM (pharmacologically selective actuator module) agonist. Activates PSAML141F-GlyR chimeric ion channels. Inhibits activity of neurons expressing PSAML141F-GlyR in vivo and activates locus coeruleus noradrenergic neurons expressing PSAML141F,Y115F-5-HT3 ion channels. Recommended concentration for use in mice is 5 mg kg or lower. Plasmid vectors for the transfection of cells with PSAML141F-GlyR and PSAML141F,Y115F-5-HT3 are available from Addgene. Lovett-Barron et al (2012) Regulation of neuronal input transformations by tunable dendritic inhibition. Nat.Neurosci. 15 423 PMID:22246433 |Satoh et al (2016) Context-dependent gait choice elicited by EphA4 mutation in Lbx1 spinal interneurons. Neuron 89 1046 PMID:26924434 |Atasoy et al (2012) Deconstruction of a neural circuit for hunger. Nature 488 172 PMID:22801496 |Hirschberg et al (2017) Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats. Elife 6 e29808 PMID:29027903

Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent. Target: I1-R Moxonidine Hydrochloride is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 + - 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 + - 0.25). The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein.

FFN 270 is a fluorescent false neurotransmitter (FFN). Fluorescent substrate for NET and VMAT2. Labels noradrenergic neurons and their synaptic vesicles, and enables imaging of synaptic vesicle content release from specific axonal sitesin vivo. Selectively labels NA neurons over other monoamine and CNS targets. Exhibits two resolved absorption/excitation maxima depending on solvent pH (excitation maxima: 320 nm or 365 nm, emission maxima: 475 nm).

CART(62-76)(human,rat) TFA 是一种类似神经递质的神经肽，由CART肽的62至76残基组成。该化合物能够调控纹状体去甲肾上腺素能、皮质纹状体及下丘脑在5-羟色胺能(5-HT)系统中的活性。

Dothiepin（Dosulepin; Dothep）是一种具备镇静 抗焦虑作用的抗抑郁药物。该化合物主要通过抑制去甲肾上腺素的再摄取，而非血清素，以增强去肾上腺素能神经传递。同时，Dothiepin作为组胺H1受体的拮抗剂，具备显著的镇痛活性，适用于治疗心因性面部疼痛、特发性纤维肌痛综合征或类风湿关节炎，并且不具有心脏毒性。

3-Methoxy-4-hydroxyphenylglycol (HMPG) 为一种在大脑中通过去甲肾上腺素降解而形成的代谢物，同时也作为中枢神经系统去甲肾上腺素能活性的生物标志。此外，3-Methoxy-4-hydroxyphenylglycol (HMPG) 在抑郁症和慢性精神分裂症的病理研究中具有重要用途。

Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhi